Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals
|
|
- Christiana Norton
- 6 years ago
- Views:
Transcription
1 Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals Presented by: Christopher Fortier, PharmD
2
3 Not if, but When: Drug Diversion in Hospitals Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA Disclosure of Relevant Financial Relationships The following faculty of this continuing education activity has no relevant financial relationships with commercial interests to disclose: Christopher Fortier 2 1
4 Faculty Christopher Fortier, PharmD, FASHP 3 Learning Objectives Outline the DEA s new focus on drug diversion in hospitals Describe the various national hospital diversion headlines and data specific to healthcare provider drug abuse and the opioid crisis Discuss MGH s 2-year DEA investigation experience and the results of a corrective action plan Share essential components and key strategies of a comprehensive and proactive drug diversion program 4 2
5 5 6 3
6 DEA Settlements California 2014 Settlement: $1.55 million to resolve claims it mishandled control substances Violations: Theft of between 20, ,000 hydrocodone tablets from its outpatient pharmacy in 2010 and Numerous recordkeeping errors, such as missing signatures on delivery slips and inventory adjustments, as well as missing invoices. Oklahoma 2011 Settlement: $1,000,000, Violations: Inconsistencies in narcotic inventories resulting from pharmacy transfers to Surgical center. Disclosed discrepancies to Board of Pharmacy and DEA. Distributed methadone to medical facility not registered Failed to maintain proper methadone records and inventories. Indiana 2007 Settlement: $2 million Violations: Investigation began based on allegations a pharmacy tech was stealing hydrocodone. DEA discovered that the hospital was unable to account for 623,843 hydrocodone tablets. Failed to keep accurate records and make accurate reports designed to safeguard the public against diversion. 7 Healthcare Workers 100,000 annually 1 in 10 Affects people of all demographics equally Protect patients from substandard care and infection risks 8 4
7 9 It is extremely important that pharmacies be prepared to meet this challenge by focusing closer attention on prescriptions dispensed, ensuring that hiring policies and accountability policies and procedures are sufficient to detect, discover, and respond to recent opioid drug crisis, as well as identify impaired health care workers and assist them in seeking appropriate programs for recover. - Ruth Carter, DEA spokesperson, October 2015 DEA considering rulemaking on suspicious order reporting. considering rulemaking on suspicious order reporting.html. Accessed August 27,
8 11 Agenda The MGH Experience Top 10 critical components Managing a DEA investigation Organizational resources Questions 12 6
9 Strategic Priorities Write down 5 strategic control substance diversion priorities that you plan to begin to implement when you return to your organization Share with the audience 2-3 of those strategic priorities 13 THE MGH EXPERIENCE 14 7
10 Mass General Hospital 1,000 bed academic medical center and clinics across Boston-metro area 2 million control substances dispensed annually 2.3 ADM control substance transactions annually 30,000 employees 2,400 physicians 380 pharmacy employees 3,800 nurses 450 anesthesia providers Automation 190 automated dispensing machines 85 anesthesia workstations 15 DEA Violations at MGH Major nurse diversion Failure to report within timeframe No biennial inventory Not utilizing DEA 222 for off-site license transfer Unable to provide 2 years worth of readilyretrievable ADM records 16 8
11 MGH Corrective Action Employ a full time Drug Diversion Compliance Officer Establish a drug diversion team Conduct mandatory annual training for all staff Purchasing controlled substance surveillance software ADM s having timed password-reset (90 days) and biometrics Requiring the MGH Department of Pharmacy to conduct daily operating room post case reconciliation of controlled substances dispensed, used or wasted. Requiring at least one nursing leader per clinical area to: Conduct weekly reviews of all controlled substance surveillance software anomalous usage reports for ADM s in that clinical area Conduct daily M-F reviews of controlled substances dispensed from the ADM s in that clinical area 17 MGH Corrective Action Requiring clinical nursing supervisors to review certain ADM reports on Saturdays, Sundays and holidays Requiring Associate Chief Nurses to conduct monthly compliance checks on their nursing leader direct reports Requiring trend and pattern reports to be reviewed quarterly by the DDTF During each year of this CAP, MGH will conduct a self evaluation of all its DEA registered facilities to review compliance with all requirements of the ACT MGH will maintain reports of disciplinary actions taken against employees found to have lost a significant quantity of controlled substances or found to have stolen or diverted controlled substances. MGH will complete biennial inventories of all of its DEA-registered facilities using physical counts (including all ADMs) witnessed by 2 individuals 18 9
12 MGH Corrective Action MGH will take the following corrective actions in addition to the enhanced controls: MGH will hire external auditors to conduct unannounced audits at all MGH facilities with active DEA registrations of 5 Schedule CII-V randomly chosen by the auditors. Each audit report will be reviewed and signed by the pharmacist in charge or the registrant s DEA-designated person MGH will have 30 days to cure/resolve any deficiencies identified in the audit report and efforts to cure will be documented in the report If the auditors find any discrepancies/losses, MGH will send the audit report within 5 days of the end of the 30 day period MGH will maintain audit records and make them available for the DEA upon request for up to a 2 years after the CAP expires 19 MGH SUD Strategic Initiative Multidisciplinary inpatient consult team (ACT) Post-discharge bridge clinic Opioid task force Recovery coaches Enhanced community health center treatment Education throughout MGH and broader community Research and evaluation Culture change 20 10
13 MGH ACT Admission to hospital ACT consult ACT Evaluation (MD/NP + SW) MGH Bridge Clinic SNF Residential Treatment Outpatient Treatment Discharge Ongoing ACT support throughout admission
14 Top Task force 2. Training 3. Surveillance 4. Investigation 5. Reporting 6. Auditing 7. Technology 8. Pharmacy controls 9. Human resources 10. Multidisciplinary 23 #1 TASK FORCE 24 12
15 #2 26 Drug Diversion Task Force Executive Sponsor: SVP Administration Executive Sponsor: SVP Patient Care Sr. Director Control Substance Compliance &Surveillance Nursing Quality & Safety Director & Staff Associate Chief Nurse & Staff Police & Security Director & Staff Chief Pharmacy Officer & Staff Chief Compliance Officer & Staff 25 education 13
16 Staff Education Pharmacy, nursing, anesthesia Annual mandatory training Signs and symptoms Nurse training Phase I Wasting, disposal, returning Phase II Control substance electronic surveillance training Phase III Best practices/discrepancy Phase IV Override list changes 27 Staff Education Wasting complete doses Withdrawing without an order Dropping/breaking containers Removal for discharged patient Withdrawing for patient who do need pain meds Volunteers for overtime often Removal under someone else Giving less than what was ordered Canceled transactions Duplicative doses Asks a colleague to witness a waste that has already been wasted Frequent trips to bathroom Willing to float or stay late often Long trips off unit Comes into work when not assigned or scheduled Readily volunteers to medicate other patients Volunteers to waste medication that was not administered by him/her Discrepancies between patient reports of pain relief and charted meds Consistently signing out maximum amount of narcotics 28 14
17 #3 SURVEILLANCE 29 Organizational Dashboard Nursing Measures Anomalous User and User Activity Checks. (Daily) Activity and User Checks (S S H) Shift Discrepancy Checks Pharmacy / Anesthesia Measures Post Case Reconciliation Compliance (Daily) Pharmacy Measures DEA 106 Filings Destock Null Transactions (Daily) Destock Null Transactions (Weekly) Discrepancy Checks (Daily) Dispense >5 Report (Daily) DPH Filings Global List Transaction Review (Weekly) Inventory Integrity Checks Endoscopy (Monthly) Override Report (Daily) Suspicious Order Monitoring (Monthly) Terminated Employee ADM Removal (Monthly) Annual Inventory Site Visits 30 15
18 Anomalous Usage Report 31 Nurse Discrepancy Checks Two nurses complete discrepancy check at change of shift Discrepancy identified Nurses check ADM Transaction by item report and complete review Discrepancy not resolved... Immediately call Pharmacy & notify nurse director and/or clinical nursing supervisor 32 16
19 OR Post-Case Reconciliation Post Case Reconciliation Monthly Compliance Trending (Sorted by Incident) "Y" = PCR was Compliant Months user_name y n % y n % y n % y n % y n % y n % y n % Gelineau, Amanda Maria % % % % % % Spencer, Rebecca % % % % % Greenberg, Deborah % % % % % % Levine, Amy % % % % % Lighthall, Samantha 2 0.0% % % % % % Holley, Catherine % % % % Gao, Lei % % % % % % % Walsh, Tomas % % % % % % Sayal, Puneet % % % % Bartels, David DB# % % % % % Norato, Christine % % % % % % % Yelle,Marc % % % % % % Kim, Peggy % % % % Cox, Jessica # % % % % % Vanneman, Matthew % % % % % % % Safavi, Kyan DB# % % % % % % Dougherty, Kelly % % % % % % % 33 p-content/uploads/2012/07/userlogging-lineup.jpg investigation #4 INVESTIGATION 34 17
20 Investigation Diversion Response Team Pharmacy, nursing, police & security, occupational health, HR, employee assistance Data collection time period 3 6 months, 1 2 year, depends on scenario Police & Security interview Drug screen Reporting to local police? 35 reporting #5 REPORTING 36 18
21 Reporting Utilize organizational safety report system to file loss Rule of Thumb: < or >5 Regulatory filings DPH within 7 days (<5) Massachusetts regulation DEA 106 with 24 hours (>5) Addendums within 45 days Will document what disciplinary action took place Other agencies BOP, DPH, CMS, FDA, Board of Nursing, Board of Medical Practice px-700px/far-back-can-irsaudit_30c97076e46eeec2.jpg #6 AUDITING 38 19
22 Audit Biennial inventory Trending reports Medication, location, user Post case reconciliation Employee volume comparisons Accountability audits 6 selected drug by independent auditor annually On site record audits of all DEA licenses Biennial inventory, powers of attorney, 222 forms, DEA 106 s, invoices Pharmacy employees Null transactions, destock, overrides 39 Report Trending 40 FENTANYL 50 MCG/ ML 13 FENTANYL 50 MCG/ ML FENTANYL LORAZEPAM 6 30 METHADONE 6 Number of Submissions OXYCODONE MIDAZOLAM ATIVAN (LORAZEPAM) (blank) MORPHINE SULFATE DILAUDID (HYDROMORPHONE HCL) FENTANYL (PATCH) FENTANYL 50 MCG/ ML; VERSED (MIDAZOLAM) PREGABALIN 2 VERSED (MIDAZOLAM) 2 Individually Reported Medications
23 technology #7 TECHNOLOGY 41 Automation/Technology Control substance surveillance system Automated dispensing cabinets, anesthesia workstations Biometrics Access to quick and usable data 2 years worth of readily retrievable usable data Security cameras Understanding how technology works/limitations When patients are discharged from system System configurations, upgrades 42 21
24 ers/bank_vault_3d_wallpaper- Pharmacy totes HD.jpghttp://fullhdwp.com/images/ wallpapers/bank_vault_3d_wallpa per-hd.jpg #8 PHARMACY CONTROLS 43 Ordering, Receiving, Storage, Returning Ordering Different than person receiving Limited to certain employees/poa Receiving Totes immediately to vault and processed CSOS matching Limiting vault and staff access Distribution Limited daily pulls Locked delivery cabinets Storage Patients own meds Cameras Biometrics Override list Profile vs. non profiled Downtime procedures Returning Return bins Drug waste Reverse distributors 44 22
25 Collecting Unused Medications DEA rule went into effect October 9, Collection receptacles. (b). Controlled and non controlled substances may be collected together and be comingled, although comingling is not required. (c) Collectors shall only allow ultimate users and other authorized non registrant persons in lawful possession of a controlled substance in Schedule II, III, IV, or V to deposit such substances in a collection receptacle at a registered location. Once a substance has been deposited into a collection receptacle, the substance shall not be counted, sorted, inventoried, or otherwise individually handled. (d) Collection receptacles shall be securely placed and maintained: (2) At a registered location, be located in the immediate proximity of a designated area where controlled substances are stored and at which an employee is present (e.g., can be seen from the pharmacy counter).. (g) The installation and removal of the inner liner of the collection receptacle shall be performed by or under the supervision of at least two employees of the authorized collector. 45 #9 HUMAN RESOURCES 46 23
26 Human Resources Drug testing upon hire, random? Corrective action Investigational leave, FMLA Bringing employees back after treatment 47 #10 MULTI- DISCIPLINARY 48 24
27 Multi-Disciplinary Collaboration Executive leadership Pharmacy Anesthesia Policy compliance Leadership accountability Employee corrective action Nursing Daily surveillance Discrepancies Weekly cycle counts Policy and process accountability Employee corrective action 49 OTHER AREAS OF CONSIDERATION Non pharmacy DEA licenses Non clinical hospital employees Removing employee access Policy updates Research Waste containers Patients own meds 50 25
28 WORKING WITHTHE DEA 51 Working with the DEA Legal counsel Cause or no cause Be organized Readily retrievable data Lack understanding of hospital operations and processes Accountability audits Outside auditor or consultants Implement improvements while investigation ongoing Understand hot buttons 52 26
29 Working with the DEA Which violations are you agreeing to or contesting Double counting violations How audits were conducted Precedent based on previous cases Corrective action plan 53 RESOURCES 54 27
30 Resources Dedicated resources Technology/automation Control substance surveillance software Automated dispensing cabinets Anesthesia workstations Biometrics Cameras Waste receptacles Indirect costs Nursing time Meetings Investigations 55 MGH INITIAL COSTS 56 28
31 Strategic Priorities Write down 5 strategic control substance diversion priorities that you plan to begin to implement when you return to your organization Share with the audience 2-3 of those strategic priorities 57 Resources ASHP Guidelines on Preventing Diversion of Control Substances ASHP Controlled Substances Diversion Prevention Program Elements of Implementation Use for gap analysis 58 29
32 Lessons Learned Are you looking hard enough? Proactive vs. reactive Comprehensive Multidisciplinary collaboration is critical Variety of surveillance and audit tools Resources dedicated to sustaining program Program visibility is major deterrent
33 Questions? Chris Fortier Faculty Biography & Contact Info Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer, Massachusetts General Hospital, Boston, MA Graduated from the University of Connecticut with a Doctor of Pharmacy degree in 2003 Completed a PGY-1 Practice and PGY-2 Health-System Pharmacy Administration Residency at the Medical Univ. of South Carolina in Charleston, SC Adjunct Associate Professor: Univ. of Connecticut, Northeastern University, and Massachusetts College of Pharmacy 62 31
Not if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA
Not if, but When: Drug Diversion in Hospitals Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA Healthcare workers 100,000 annually 1 in 10 Affects people
More informationTHE BASICS THE BASICS STAFF EDUCATION DRUG DIVERSION TASK FORCE 4/8/2016. MSHP Annual Meeting 2016
/8/01 MSHP Annual Meeting 01 DEA Audit and Investigation Lessons Learned: Training, Reporting, Surveillance, Auditing and Technology Erasmo (Ray) Mitrano, RPh, MS, Senior Director Controlled Substance
More informationA Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS
A Million Little Pieces: Developing a Controlled Substance Diversion Program Tanya Y. Barnhart, PharmD, BCPS I have no conflicts of interest to disclose Objectives Explain the importance of building a
More informationPatient Safety. Road Map to Controlled Substance Diversion Prevention
Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/
More informationPharmaceutical Diversion Prevention, Detection and Incident Response
Pharmaceutical Diversion Prevention, Detection and Incident Response HIPAA Security Officer, Mount Sinai Health System President, Society of Professional Investigators Associate Director of Administration
More informationUnderstanding Diversion in the Pharmacy Kimberly S. New JD BSN RN
Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN All Rights Reserved Scope of the Problem Diversion can t be prevented entirely Substantial safety, quality, regulatory and legal risk Mitigate
More informationMedication Management and Diversion Control
Medication Management and Diversion Control Karla M Miller, Pharm D July 2017 January 18, 2017 NEWS Surgery Center Director Removed from Position after Alleged Drug Theft Director of the surgery center
More informationMedication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives
Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting Objectives Discuss: Learn about signs of potential diversion and recognize an impaired healthcare provider. Help to identify
More informationData Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement
Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement This presentation will cover The Wake-up call How we incorporated data analytics into our diversion detection
More informationDrug Diversion Prevention The Mayo Clinic Experience
Drug Diversion Prevention The Mayo Clinic Experience Kevin R. Dillon, Pharm.D., MPH Director of Pharmacy Services Mayo Clinic Health Care Compliance Association Upper Midwest - Regional Annual Conference
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationCHAPTER 18 CONTROLLED SUBSTANCES
CHAPTER 18 CONTROLLED SUBSTANCES 18.1 CONTROLLED SUBSTANCES Hospital DEA DEA assigned to facility (vs. the pharmacy) Registrant is entity vs. individual Renewal every 3 years, can renew & manage registration
More informationUnderstanding Diversion
Drug Diversion Prevention, Detection and Response Programs: Essential Knowledge for the Healthcare Professional John Burke, President, IHFDA Kimberly New, Executive Director, IHFDA 2016 All Rights Reserved
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 9:45 am 11:15 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: How to Be
More informationScope of the Problem. Leadership Engagement. Leadership Engagement. Risk of Harm to Patients. Risk of Harm to Patients 6/13/2016
Protecting Patients from Harm: Establishing an Institutional Diversion Program Kimberly S. New JD BSN RN Scope of the Problem All facilities face this issue Diversion can t be prevented entirely Substantial
More informationPREPARATION AND ADMINISTRATION
LESSON PLAN: 12 COURSE TITLE: UNIT: IV MEDICATION TECHNICIAN PREPARATION AND ADMINISTRATION SCOPE OF UNIT: Guidelines and procedures for preparation, administration, reporting, and recording of oral, ophthalmic,
More informationIt s every OR manager s nightmare a drug diversion that hits the local
Substance abuse Drug diversion in the OR: How can you keep it from happening? It s every OR manager s nightmare a drug diversion that hits the local news. That nightmare came true for 2 Colorado facilities
More informationMINNESOTA BOARD OF PHARMACY
MINNESOTA BOARD OF PHARMACY Prescription Drug Waste Reduction Report. (In compliance with Minnesota Session Laws, 2010 First Special Session, Chapter 1, section 21) Cody Wiberg, Pharm.D., M.S., R.Ph. Executive
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationGalveston Area Ambulance Authority Controlled Substance Guidelines
Controlled Substance Guidelines Revised September 2015 Version 2.0 Intent The following policy will define the usage, waste and tracking of all controlled substances within the Galveston Area Ambulance
More informationROUND LAKE Journey Toward Healthy. Treatment Centre
ROUND LAKE Treatment Centre Culture is Treatment HARM REDUCTION HARM REDUCTION Photo Credits: Carla Hunt HARM REDUCTION WELLNESS IS A JOURNEY NOT A DESTINATION (FNHA) OPIOID AGONIST THERAPY METHADONE SUBOXONE
More informationCONSULTANT PHARMACIST INSPECTION LAW REVIEW
CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationGood Practice Guidance : Safe management of controlled drugs in Care Homes
Good Practice Guidance : Safe management of controlled drugs in Care Homes Date produced: April 2015; Date for Review: April 2017 Good Practice Guidance documents are believed to accurately reflect the
More informationPACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 7 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationPHARMACY IN-SERVICE Pharmacy Procedures for New Nursing Staff
PHARMACY IN-SERVICE Pharmacy Procedures for New Nursing Staff OVERVIEW COMMUNICATION: THE KEY TO SUCCESS GOOD COMMUNICATION BETWEEN THE FACILITY AND THE PHARMACY IS ESSENTIAL FOR EFFICIENT SERVICE AND
More informationPurpose This procedure provides guidance on the use and documentation of Controlled Medications
Controlled Medications HELI.CLI.20 Purpose This procedure provides guidance on the use and documentation of Controlled Medications For Review Aug 2015 1. Introduction 2. Definitions Aeromedical Retrieval
More informationDevelopment of a Road Map to Controlled Substance Diversion Prevention
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing In the news. Prison Sought for Nurse Who Stole
More informationDOD INSTRUCTION DRUG TAKE BACK PROGRAM
DOD INSTRUCTION 6025.25 DRUG TAKE BACK PROGRAM Originating Component: Office of the Under Secretary of Defense for Personnel and Readiness Effective: April 26, 2016 Releasability: Approved by: Cleared
More informationImplementing Systems for Detection and Prevention of Drug Diversion
Implementing Systems for Detection and Prevention of Drug Diversion Mitch Sobel, RPh, Assistant Director of Pharmacy Services Saint Barnabas Medical Center, Livingston, New Jersey Aline Greene, RN, CEN,
More informationUpdated FY15 Dignity Health General Compliance Education for Staff Module 2
Updated FY15 Dignity Health General Compliance Education for Staff Module 2 This course will provide you with important information about the laws and regulations that affect the healthcare industry, our
More informationDrug Diversion Exercise. New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016
Drug Diversion Exercise New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016 What is Drug Diversion When prescription medicines are obtained or used illegally This
More informationSupporting The Joint Commission 2012 Standards and National Patient Safety Goals
Supporting The Joint Commission 01 Standards and National Patient Safety Goals for Pyxis technologies This document highlights select Joint Commission 01 Standards and National Patient Safety Goals mapped
More informationHow to Detect and Prevent Drug Diversion - Lessons from an Academic Medical Center. Session Objectives
How to Detect and Prevent Drug Diversion - Lessons from an Academic Medical Center Presenters Tim Marshall, Director, Oregon Health & Science University Meaghan Smith, Lead Auditor, Oregon Health & Science
More informationa remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.
Board of Pharmacy Administrative Rules Version 12 January 18, 2013 Part 19 Remote Pharmacies 19.1 General Purpose: (a) This Part is enacted pursuant to 26 V.S.A. 2032 which initially authorized the Board
More informationCalifornia Pharmacy Law Update 2018
California Pharmacy Law Update 2018 Virginia Herold Executive Officer California State Board of Pharmacy Tony J. Park, Pharm.D., J.D. California Pharmacy Lawyers Statutory Mandate Protection of the public
More information(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-
420-5-10-.16 Pharmacy Services. (1) The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in 483.75(h) of Title 42 Code of
More informationMEDCOM Medication Management Discussion
MEDCOM Medication Management Discussion 2009 MEDCOM-TJC Conference Manager, Army Patient Safety Program Quality Management Office HQ, US Army Medical Command Fort Sam Houston, TX 19 Nov 2009 BRIEFING OUTLINE
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationDepartment of Health and Mental Hygiene Springfield Hospital Center
Audit Report Department of Health and Mental Hygiene Springfield Hospital Center April 2009 OFFICE OF LEGISLATIVE AUDITS DEPARTMENT OF LEGISLATIVE SERVICES MARYLAND GENERAL ASSEMBLY This report and any
More informationPolicies and Procedures for LTC
Policies and Procedures for LTC Strictly confidential This document is strictly confidential and intended for your facility only. Page ii Table of Contents 1. Introduction... 1 1.1 Purpose of this Document...
More informationAudience Poll Questions
Pharmacy Drug Procedures and Proper Documentation Ana Fernandez, CPhT Northwestern Memorial Hospital Department of Investigational Drug Chicago, Illinois The speaker has no conflicts to disclose. Audience
More informationHB 1 Regulations Board of Medical Licensure
HB 1 Regulations Board of Medical Licensure C. Lloyd Vest II, J.D. General Counsel Kentucky Board of Medical Licensure Faculty Disclosure I have not had any relevant financial relationships during the
More information2016 Plan of Correction Data 1
2016 Plan of Correction Data 1 Retail Data Calendar Year 2015 2016 Number of Inspections 1263 1694 number of Plan of Correction s (POC s) issued 502 523 Regulatory Citations 2 & 2015 2016 number of POC
More informationObjectives. Institutional Pharmacy Practice. Medicare, Medicaid, What s the difference? Medicare, Medicaid, What s the difference?
Objectives Institutional Pharmacy Practice Donald H. Williams, RPh, FASHP Affiliate Professor University of Washington To discuss the regulation of institutional pharmacy practice in Washington To differentiate
More informationFrequently Asked Questions
1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation
More informationObjectives. Institutional Pharmacy Practice. Medicare, Medicaid, What s the difference? Medicare Modernization Act
Objectives Institutional Pharmacy Practice Donald H. Williams, RPh, FASHP Affiliate Professor University of Washington To discuss the regulation of institutional pharmacy practice in Washington To differentiate
More informationTexas Pharmacy Law Update
Texas Pharmacy Law Update Speaker Disclosure Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director/Secretary Texas Chapter of the American Society of Consultant Pharmacists January 27, 2018 The presenter
More informationNEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
More informationRobert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014
Robert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014 Introduction : Introduction The prescription drug abuser, or drug seeker, represents a serious and constant
More informationNOTES AND ACTIONS. Turn off power switch, wait a few seconds, turn back on. If paper jammed, remove and reinsert.
POLICY All ADCs will be plugged into the C&W Emergency Power (RED) plugs. In the event that the main BC Hydro power is off, the cabinets should still run on the Emergency Power system (C&W back up generators).
More informationTABLE OF CONTENTS. Newsletters. Table of Contents/Introduction. Glossary. Part 1300 Definitions
TABLE OF CONTENTS Newsletters Table of Contents/Introduction Page Table of Contents... i Current Contents...xxiii Drug Enforcement Administration... 2 DEA Offices and Organization... 3 DEA Field Division
More information2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017
2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen
More informationDrug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06
Drug Distribution Services for Long Term Care Facilities Susan L. Lakey, PharmD 1/11/06 Drug distribution The process: Receipt / transcription of order Interpretation / evaluation of order Filling and
More informationPharmaceutical Services Requirements: formerly 10D and 10C.7
Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure
More informationTexas Administrative Code
RULE 19.1501 Pharmacy Services A licensed-only facility must assist the resident in obtaining routine drugs and biologicals and make emergency drugs readily available, or obtain them under an agreement
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationThe Introduction of Automated Medication Management and Dispensing System with Omnicell
The Introduction of Automated Medication Management and Dispensing System with Omnicell The Introduction of Automated Medication Management and Dispensing System with Omnicell Sinead Fisher Clinical Nurse
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationCompliance Made Simple: 24/7/365
9/27/13 A webinar series that keeps you in the know Brought to you by Progressive Compliance Made Simple: 24/7/365 ì Crissy Benze, RN, BSN Progressive Huddle September 30, 2013 Objectives Know what to
More informationSELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES
MENTAL HEALTH DIRECTORATE POLICY SELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES Originator: Mental Health Policies and Procedures Group
More informationTABLE OF CONTENTS. Page OBJECTIVES, SCOPE AND METHODOLOGY... 1 BACKGROUND Organizational Structure and Personnel... 4
TABLE OF CONTENTS Page OBJECTIVES, SCOPE AND METHODOLOGY... 1 BACKGROUND... 2 Organizational Structure and Personnel... 4 Financial Information... 5 FINDINGS AND RECOMMENDATIONS... 6 1. Financial Management...
More informationCritical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital
Critical Access Hospitals Site Visit Summary 2014 2015 Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital 2014 2015 13 Critical Access Hospitals (CAH) Site Visits Compounded
More informationStephen C. Joseph, M.D., M.P.H.
JUL 26 1995 MEMORANDUM FOR: ASSISTANT SECRETARY OF THE ARMY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE NAVY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE AIR FORCE (MANPOWER, RESERVE
More informationOptimizing Medication Distribution using Automated Dispensing Cabinets
Optimizing Medication Distribution using Automated Dispensing Cabinets Conflict of Interest Declaration I have no actual or potential conflicts of interest in relation to this presentation or activity
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MANAGEMENT OF PATIENT S OWN MEDICATIONS SCOPE Provincial: Inpatient Settings, Ambulatory Services, and Residential Addiction and Detoxification Settings APPROVAL AUTHORITY Clinical Operations Executive
More informationCPhT Program Recognition Attestation Form
About this Form Beginning in 2020, CPhT applicants must have completed a PTCB-recognized education/training program or have equivalent work experience in order to be eligible for certification. The purpose
More informationTeaching Institution Application for Registration (Form DHHS 224-C)
Teaching Institution Application for Registration (Form DHHS 224-C) NC Department of Health and Human Services Division of Mental Health, Developmental Disabilities, and Substance Abuse Services Drug Control
More informationFrom Big Data to Big Knowledge Optimizing Medication Management
From Big Data to Big Knowledge Optimizing Medication Management Session 157, March 7, 2018 Dave Webster, RPh MSBA, Associate Director of Pharmacy Operations, URMC Strong Maria Schutt, EdD, Director Education
More informationINSITE : Medication Management for Long-Term Care
INSITE : Medication Management for Long-Term Care InSite in-facility medication packaging and delivery technology by Talyst enables secure, automated medication dispensing on location at long-term care
More informationManagement of Controlled Substances Ambulatory Care with Electronic Key Control Cabinet
Management of Controlled Substances Ambulatory Care with Electronic Key Control Cabinet UI Internal Audit Education Responses/Fall 2009 Revised 10/14/09 1 Management of Controlled Substances There have
More informationPHARMACY RULES COMMITTEE of the PHARMACY EXAMINING BOARD
Wisconsin Department of Safety and Professional Services Division of Policy Development 1400 E. Washington Ave PO Box 8366 Madison WI 53708-8366 Phone: 608-266-2112 Web: http://dsps.wi.gov Email: dsps@wisconsin.gov
More informationEpic Pain Management & Anesthesia Consultants, LLC PO Box 1779, Fort Lee, NJ REGISTRATION FORM
REGISTRATION FORM Name (First) (Middle) (Last) M F Social Security of Birth Age Marital Status Single Married Civil Union Widow/ Widower Home Address City State Zip Code Work Address (Cell) (Home) (Work)
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationKroll Version 10 Service Pack 14. Release notes
Kroll Version 10 Service Pack 14 Release notes June 2018 Table of Contents Kroll Version 10 Service Pack 14 Release Notes...3 User Interface...3 [45822] Create New Rx from To Do screen enhancement...3
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationThe Colorado ALTO Project
Using Alternatives to Opioids (ALTOs) in Hospital Emergency Departments PRE-LAUNCH CHECKLIST Based on the 2017 Opioid Prescribing & Treatment Guidelines Colorado ALTO Project Champion Sets the direction
More informationHealthcare Facility Drug Diversion: America s Best Kept Secret. Kimberly S. New JD BSN RN
Healthcare Facility Drug Diversion: America s Best Kept Secret Kimberly S. New JD BSN RN Discussion Points Scope of the problem Reporting requirements Profile and predisposing factors Impact on the patient
More informationbeyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015
beyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015 Lidia A. Rodriguez-Hupp SVP & 340B Compliance Officer Christopher Boles Regional VP,
More informationAHLA. T. Diversion of Controlled Substance in Health Care Setting
AHLA T. Diversion of Controlled Substance in Health Care Setting Lorri Hall Abramowitz Drug Diversion Specialist UF Health Jacksonville Jacksonville, FL Ann M. Bittinger The Bittinger Law Firm Jacksonville,
More informationNon-Employee and Employee Incident Reporting
Non-Employee and Employee Incident Reporting Training Objectives 1. Completing and submitting an incident form: a. for an employee (Employee Incident) b. for a patient/person involved incident (Non-Employee
More informationSTANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.
STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation
More informationMEDICATION ADMINISTRATION POLICY POLICY, PROCEDURES, & GUIDELINES FOR MEDICATION ADMINISTRATION II. PROCEDURES FOR MEDICATION ADMINISTRATION
Insytt-ma-procedures 08-09; 02-17 page 1 of 7 MEDICATION ADMINISTRATION POLICY POLICY, PROCEDURES, & GUIDELINES F MEDICATION ADMINISTRATION II. PROCEDURES F MEDICATION ADMINISTRATION Procedures used for
More informationPromotion of Consumer Health and Safety. A. Safe Medication Assistance and Administration Policy
3. Promotion of Consumer Health and Safety A. Safe Medication Assistance and Administration Policy 1. Policy: a. It is the policy of this DHS license provider Meridian Services, Incorporated s to provide
More informationPharmacy Law Home Study for Pharmacists and Pharmacy Technicians Preparing Your Pharmacy for a DEA Inspection
Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians (Knowledge-Based CPE Activity) No sponsorship was received for this law program Program Goal and Objectives The purpose of this home study
More informationA powerful medication management tool for the new healthcare environment
Pyxis ES platform: A powerful medication management tool for the new healthcare environment Introduction Medication management practices have become more complex and demanding as the continuum of care
More informationCONTROLLED DRUG GUIDE FOR CARE HOMES
CONTROLLED DRUG GUIDE FOR CARE HOMES Controlled drugs are prescription drugs controlled under the misuse of drugs legislation and subsequent amendments. These are drugs, substances or chemicals whose manufacture,
More informationManagement of Controlled Substance
Management of Controlled Substance Ambulatory Care UI Internal Audit Education Responses/Fall 2009 Revised 10/14/09 1 Management of Controlled Substances There have been several changes made to the policies
More informationSECTION HOSPITALS: OTHER HEALTH FACILITIES
SECTION.1400 - HOSPITALS: OTHER HEALTH FACILITIES 21 NCAC 46.1401 REGISTRATION AND PERMITS (a) Registration Required. All places providing services which embrace the practice of pharmacy shall register
More informationLicensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationImproving Primary Care Medication Patient Safety: System-level Medication Adherence Issues
Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues Marie Smith, PharmD Professor and Asst. Dean, Practice and Public Policy Partnerships Meg Mello Moniz, PharmD
More informationPharmacy Leadership and Administration Learning Experience Rev 12/16/16
Pharmacy Leadership and Administration Learning Activities (Longitudinal): Preceptors: Jordan Dow, PharmD MS FACHE (Regional Pharmacy Director); Michele Richmond, RPh (Outpatient Pharmacy Director); Maggie
More informationPOSITION STATEMENT. - desires to protect the public from students who are chemically impaired.
Page 1 of 18 POSITION STATEMENT The School of Pharmacy and Health Professions: - desires to protect the public from students who are chemically impaired. - recognizes that chemical impairment (including
More informationStorage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431
Centers for Medicare & Medicaid Services (CMS) Storage, Labeling, Controlled Medications Instructor s Guide CFR 483.60(b)(2)(3)(d)(e) F431 2006 Prepared by: American Institutes for Research 1000 Thomas
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017 What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide
More informationSubmitted electronically via: May 20, 2015
Submitted electronically via: http://www.regulations.gov May 20, 2015 Jane Axelrad, JD Associate Director for Policy, CDER Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationMedication Storage and Security: The #1 Non- Complaint Medication Management Standard
Learning Objectives and Security: The #1 Non- Complaint Medication Management Standard d Manager, Army Patient Safety Program U.S. Army Medical Command Fort Sam Houston, TX Describe the importance of maintaining
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More information